Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 9/20 | 0.49 |
| ▸ | NTSR2 | O95665 | 8/20 | 0.49 |
| ▸ | CALCR | P30988 | 4/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.48 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.47 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.47 |
| ▸ | SORT1 | Q99523 | 7/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31319372 | 0.89 | F2 (0.52) | F2NTSR1NTSR2RENSORT1 | |
| SCHEMBL31319367 | 0.87 | REN (0.53) | F2NTSR1NTSR2RENSORT1 | |
| SCHEMBL30168719 | 0.86 | F2 (0.53) | F2NTSR1NTSR2CALCRREN | |
| SCHEMBL31256944 | 0.86 | LNPEP (0.55) | NTSR1NTSR2RENSORT1AGTR1 | |
| SCHEMBL30539396 | 0.85 | NTSR1 (0.53) | F2NTSR1NTSR2CALCRREN | |
| SCHEMBL30426901 | 0.85 | REN (0.50) | F2NTSR1NTSR2RENSORT1 | |
| SCHEMBL31465300 | 0.85 | F2 (0.52) | F2NTSR1NTSR2RENSORT1 | |
| SCHEMBL30382454 | 0.84 | F2 (0.52) | F2CALCRHCRTR1HCRTR2 | |
| SCHEMBL30382943 | 0.83 | F2 (0.53) | F2NTSR1NTSR2CALCRHCRTR1 | |
| SCHEMBL29674857 | 0.83 | F2 (0.52) | F2CALCRRENAGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |